Dr. David J. Sher, MD

Dr. Sher practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Sher's NPI, 1326028648, was assigned on January 20, 2006. Dr. Sher graduated from Harvard Medical School in 2003. Dr. Sher's Massachusetts license number on file is 223229.

Dr. Sher's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Sher's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Sher is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Sher to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sher practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sher's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Sher is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Sher's licenses on file in 3 states: Massachusetts, Texas and Illinois.

Dmand AI lists bone cancer radiation, cancer radiation-upper GI, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Sher treats.

CMS data shows 2,447 Medicare services from Dr. Sher across 16 procedure codes in 2024, for 217 Medicare patients. Medicare paid $153,598 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 217 Medicare patients who saw Dr. Sher in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sher's median patient age at 68, with 27% women.

In 2024, Dr. Sher wrote 422 Medicare Part D claims for 122 patients. 98% of them were for generic drugs. CMS names the drug for 316 of them, across 10 drugs with 11 or more claims each, at $9,454 in total drug cost. In 2023, CMS named 261 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sher for performance year 2024, reported individually. Dr. Sher accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 181 papers to Dr. Sher, published from 2004 to 2025. 2022 was the busiest year, with 20. The most frequent topics are Head and Neck Neoplasms, Radiotherapy, Intensity-Modulated and Radiotherapy Dosage. Dr. Sher has published most often in Int J Radiat Oncol Biol Phys. Dr. Sher's most frequent co-authors are Baran D. Sumer, MD, Dominic Himchan Moon, MD and Andrew T. Day, MD.

Dmand AI links Dr. Sher to 6 clinical trials, 2 of them phase 2 studies. Conditions studied include Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms and Adenocarcinoma. University of Texas Southwestern Medical Center sponsors the most, 4.

CMS Open Payments shows 4 general payments to Dr. Sher from 2 drug and device companies in 2022. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $139.

Dr. Sher graduated from Harvard Medical School in 2003.

Dr. Sher is in network with 20 carriers, including Elevance, United Healthcare and Aetna. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.